Cytomegalovirus retinitis and the lupus anticoagulant syndrome.
Margo
C E
CE
Section of Ophthalmology, James A. Haley Veterans Hospital, and the University of South Florida, College of Medicine, Tampa, USA.
Arango
J L
JL
D000998:Antiviral Agents / Q000627:therapeutic use; D001706:Biopsy; D003587:Cytomegalovirus / Q000235:genetics; D017726:Cytomegalovirus Retinitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D004279:DNA, Viral / Q000032:analysis; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D053685:Laser Therapy; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012160:Retina / Q000473:pathology / Q000601:surgery; D012166:Retinal Hemorrhage / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D013577:Syndrome; D014821:Vitrectomy; D014822:Vitreous Body / Q000473:pathology / Q000601:surgery / Q000821:virology
D000998:Antiviral Agents; D004279:DNA, Viral; D005938:Glucocorticoids; D016682:Lupus Coagulation Inhibitor